{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T01:22:05Z","timestamp":1755220925587,"version":"3.43.0"},"reference-count":12,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Anti-Ma2 antibody encephalitis is a rare paraneoplastic autoimmune encephalitis (AE) caused by anti-Ma2 antibody. Creutzfeldt-Jakob disease (CJD), a group of human prion diseases, is a rapidly advancing and fatal neurodegenerative disorder. The two diseases may display comparable clinical symptoms that are easily misdiagnosed. The 14-3\u20133 protein in the Cerebrospinal fluid (CSF) is considered a valuable marker for diagnosing CJD. In this report, we discussed a case of anti-Ma2 antibody encephalitis in which the CSF showed positive results for 14-3\u20133 protein, a new instance of antibody coexistence.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case presentation<\/jats:title><jats:p>A 77-year-old man was hospitalized due to his recent rapid progression of memory loss, mental and behavioral abnormalities, and gait disturbance. Brain CT showed no abnormalities. The detection of antineuronal antibodies in serum and CSF using Western blot revealed positive high titers for anti-Ma2 antibody. Surprisingly, the 14-3\u20133 protein in CSF was positive. Subsequently, FLAIR magnetic resonance imaging showed abnormal regions with heightened signal intensity in the bilateral mesial temporal lobes, amygdala, and hippocampus. Electroencephalography, real-time quaking-induced conversion in CSF, and prion protein gene in blood were detected to distinguish from CJD, and these findings did not match the diagnosis of CJD. Finally, the patient was treated with intravenous methylprednisolone, intravenous immunoglobulin (IVIG), and rituximab. The patient\u2019s condition was effectively improved.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Anti-Ma2 antibody encephalitis is a type of encephalitis associated with autoantibodies targeting intracellular antigens. Previous studies have detected the presence of 14-3\u20133 protein in some cases of AE associated with antibodies against neuronal surface antigens. This is the first report of concomitant anti-Ma2 antibody and CSF 14-3\u20133 protein positivity, which is a further extension of previous studies. This case demonstrates that CSF 14-3\u20133 protein positivity does not preclude AE and may reflect secondary neuronal injury. When both antibodies are present simultaneously, the diagnosis should be made in combination with the patient\u2019s imaging features, prion-specific testing and high titers of antineuronal antibodies to avoid delay in treatable disease.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2025.1598626","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T05:25:45Z","timestamp":1754630745000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Coexistence of CSF anti-Ma2 antibody and 14-3-3 protein: a diagnostic dilemma between autoimmune encephalitis and Creutzfeldt-Jakob disease, a Case Report"],"prefix":"10.3389","volume":"16","author":[{"given":"Nianlong","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liangyu","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengqing","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,8,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2019.03.017","article-title":"Fatal anti-ma2 encephalitis related to treatment of Malignant pleural mesothelioma with a combination of anti-programmed death 1 and anti-cytotoxic T-lymphocyte associated protein 4 antibodies","volume":"14","author":"Du Rusquec","year":"2019","journal-title":"J Thorac Oncol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-014-0227-7","article-title":"Creutzfeldt-Jakob disease mimicking autoimmune encephalitis with CASPR2 antibodies","volume":"14","author":"Zuhorn","year":"2014","journal-title":"BMC Neurol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3233\/jad-220718","article-title":"Clinical correlates of cerebrospinal fluid 14-3\u20133 protein in non-prion rapid progressive dementia","volume":"91","author":"Kong","year":"2023","journal-title":"J Alzheimers Dis"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e1039","DOI":"10.1212\/nxi.0000000000001039","article-title":"Autoimmune encephalitis resembling dementia syndromes","volume":"8","author":"Bastiaansen","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2017.04.007","article-title":"Lower dosages of rituximab used successfully in the treatment of anti-NMDA receptor encephalitis without tumour","volume":"377","author":"Wang","year":"2017","journal-title":"J Neurol Sci"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2019.02.008","article-title":"Reduced dosage rituximab in the treatment of anti-N-methyl-d-aspartate receptor encephalitis: An observation study in Chinese patients","volume":"330","author":"Deng","year":"2019","journal-title":"J Neuroimmunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31826d5fc3","article-title":"Evidence-based guideline: diagnostic accuracy of CSF 14-3\u20133 protein in sporadic Creutzfeldt-Jakob disease: report of the guideline development subcommittee of the American Academy of Neurology","volume":"79","author":"Muayqil","year":"2012","journal-title":"Neurology"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2014-308695","article-title":"Neuronal antibodies in patients with suspected or confirmed sporadic Creutzfeldt-Jakob disease","volume":"86","author":"Rossi","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B9","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/ana.24833","article-title":"Diagnostic and prognostic value of human prion detection in cerebrospinal fluid","volume":"81","author":"Foutz","year":"2017","journal-title":"Ann Neurol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2006.03.004","article-title":"14-3\u20133 proteins as potential oncogenes","volume":"16","author":"Tzivion","year":"2006","journal-title":"Semin Cancer Biol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aws082","article-title":"Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis","volume":"135","author":"Bien","year":"2012","journal-title":"Brain"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2020.1319","article-title":"Evaluation of a new criterion for detecting prion disease with diffusion magnetic resonance imaging","volume":"77","author":"Bizzi","year":"2020","journal-title":"JAMA Neurol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1598626\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T05:25:45Z","timestamp":1754630745000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1598626\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,8]]},"references-count":12,"alternative-id":["10.3389\/fimmu.2025.1598626"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1598626","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,8]]},"article-number":"1598626"}}